We’re ready for an eventful September! Looking forward to attending upcoming #Conferences and sharing the latest on our #Retina pipeline at: 👉 Morgan Stanley Annual Global Healthcare Conference 👉 Baird Global Healthcare Conference 👉 Cantor Global Healthcare Conference 👉 UBS Virtual Ophthalmology Day Check out the detailed list of #Investor conferences we will be attending next month here: https://lnkd.in/erzDP588
EyePoint Pharmaceuticals
Biotechnology Research
Watertown, MA 12,342 followers
Delivering Innovation to the Eye™ NOW HIRING!
Über uns
EyePoint Pharmaceuticals (Nasdaq: EYPT) is a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders. The Company's pipeline leverages its proprietary Durasert® technology for sustained intraocular drug delivery including EYP-1901, a potential six-month intravitreal anti-VEGF treatment initially targeting wet age-related macular degeneration. Durasert’s proven intravitreal drug delivery platform has been safely administered to thousands of patients' eyes across four U.S. FDA-approved products, including YUTIQ® for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye, which is currently marketed by the Company. EyePoint Pharmaceuticals is headquartered in Watertown, Massachusetts.
- Website
-
http://www.eyepointpharma.com
External link for EyePoint Pharmaceuticals
- Industrie
- Biotechnology Research
- Größe des Unternehmens
- 51-200 Mitarbeiter
- Hauptsitz
- Watertown, MA
- Typ
- Öffentliches Unternehmen
- Spezialitäten
- Ophthalmology, Glaucoma, WetAMD, Optometry, Eye Disease, and Retinal Disease
Standorte
-
480 Pleasant St., Suite B300
Watertown, MA 02472, US
Employees at EyePoint Pharmaceuticals
Aktualisierungen
-
Members of the #EYPT team were honored to attend the Women in Ophthalmology 2024 Summer Symposium. We were grateful to join women leaders in #Ophthalmology for a day of collaboration, education and networking. Check out some highlights below!
-
-
#Innovation is at our core. #EYPT specializes in the development of sustained-release drug delivery to treat debilitating diseases of the eye and other localized, chronic conditions. Learn more: https://lnkd.in/dGEF4u5M
-
Our #EYPT team is headed to Carlsbad, CA for the Women in Ophthalmology 2024 Summer Symposium! We look forward to a great few days of networking, learning and collaborating with trailblazers who are paving the way in the #Ophthalmology field.
-
-
“The most important asset that any organization has is its people.” – Jay Duker, #EYPT President and CEO Hear more from Jay in his interview with OWL: Advancing Diversity in Leadership here: https://lnkd.in/eKDGhKJN
-
-
#NOWHIRING | Medical Director, Clinical Development – Ophthalmology #EYPT is now hiring for a fully #Remote #MedicalDirector with a medical degree (MD - specialization in ophthalmology or Dr. of Optometry) and 2-4 years of experience in a clinical trial environment to be the primary sponsor medical person of contact for our clinical trials. Join a passionate team, committed to preventing blindness through innovative therapies today: https://lnkd.in/exnESHEQ #Careers #DEI #Inclusion #Diversity #ClinicalResearch Sherry Jenkins McHale, Theresa DiBiase, Monica Roy
-
-
#EYPT is committed to developing therapeutics to improve the lives of patients with serious retinal diseases. Our pipeline leverages proprietary technology for sustained intraocular drug delivery. Learn more about our #Pipeline & #Technology here: https://lnkd.in/dGEF4u5M
-
-
Please join us in congratulating our 2024 #Intern class! Each of these talented students worked hard during this program to grow their skills and provided invaluable work across our team. We celebrated their last day with well-deserved certificates from our President & CEO, Jay Duker. We see a bright future for each of you – congratulations!
-
-
-
-
-
+6
-
-
#EYPT is committed to developing solutions for patients facing serious #Retinal diseases, through our dedication to #Innovation, #Science and #Technology. Find out more here: https://lnkd.in/dGEF4u5M
-
Back to school time! In partnership with Life Science Cares Boston, EyePoint employees assembled backpacks full of necessities – binders, notebooks, highlighters, pencils, pens, folders and much more – to be delivered to Youth, Purpose & Partnership (YPP) students at Children's Services of Roxbury, Inc. (CSR) CSR brings peace of mind to Massachusetts’ most vulnerable families, providing housing for homeless families, affordable childcare, children’s mental health services, intensive foster care, and youth development programs. We were honored to be able to contribute to their important mission and deliver 48 backpacks for YPP students. Thank you to all who participated!
-
Verbundene Seiten
Ähnliche Seiten
Jobs durchsuchen
Finanzierung
Letzte Runde
Eigenkapital nach dem IPOUS$ 215.9M